Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
Premium Content
Special Reports
Top 10 News for 05/13 - 05/17: Tesla Can't be Stopped; Tepper Still Bullish; Sony Gets in Play
Notable 52-Week Highs and Lows of the Day 05/15: (RAD) (SCTY) (TSO) High; (SHZ) (AU) Low
Unusual 11 Mid-Day Movers 05/17: (RSOL) (SCTY) (VNDA) Higher; (ARUN) (UNXL) (COSI) Lower
Send to a Friend
Font Size:
Increase
Decrease
ANTH and GSK Related Headlines
Go Back
Jun 29, 2012 06:59AM
Human Genome (HGSI) Could Get 15% More in Takeover Bid - Analyst
ANTH and GSK Related Press Releases
Go Back
ANTH and GSK Related SEC Filings
Go Back
